Novartis, Valeant bids herald new deal-making era for pharma
Novartis, Valeant bids herald new deal-making era for pharma Yahoo/Reuters
View ArticleWhy Valeant International Inc. Is Acquiring Botox and Juvederm Maker Allergan
Why Valeant International Inc. Is Acquiring Botox and Juvederm Maker Allergan Motley Fool
View ArticleAllergan poison pill presages a battle against Valeant's $47B takeover
Allergan poison pill presages a battle against Valeant's $47B takeover Fierce Pharma
View Article[video] Why Is the Drug Industry in a Deal Frenzy?
[video] Why Is the Drug Industry in a Deal Frenzy? Bloomberg
View ArticleAllergan sales force key to Valeant chief's plans for post-merger growth
Allergan sales force key to Valeant chief's plans for post-merger growth Fierce Pharma Marketing
View ArticleAllergan can do better than Valeant offer, investor says
Allergan can do better than Valeant offer, investor says Mass Device
View ArticleAllergan made a pass at Shire before Valeant came calling
Allergan made a pass at Shire before Valeant came calling Fierce Biotech
View ArticleAllergan likely to receive higher bid from Valeant, says Sterne Agee
Allergan likely to receive higher bid from Valeant, says Sterne Agee Yahoo/Fly on the Wall
View ArticleIrreconcilable differences? Allergan investors wary of suitor Valeant's...
Irreconcilable differences? Allergan investors wary of suitor Valeant's cost-slashing style Fierce Pharma
View ArticleAllergan Said to Explore Sale to Sanofi, J&J
Allergan Said to Explore Sale to Sanofi, J&J Bloomberg
View ArticleShire Gains on Report Allergan Is Preparing Takeover Bid
Shire Gains on Report Allergan Is Preparing Takeover Bid Bloomberg
View ArticleUp, up, up: After Allergan offer, would-be buyer Ackman reaps $1.2B in gains
Up, up, up: After Allergan offer, would-be buyer Ackman reaps $1.2B in gains Fierce Pharma
View ArticleAllergan Reports Strong Q1 While Weighing Valeant Bid
Allergan Reports Strong Q1 While Weighing Valeant Bid Investors.com
View ArticleAllergan board unanimously rejects cash-stock takeover offer from Valeant Pharma
Allergan board unanimously rejects cash-stock takeover offer from Valeant Pharma Yahoo/AP
View ArticleAllergan CEO says 'rumor mill' inconsistent with company history of discreteness
Allergan CEO says 'rumor mill' inconsistent with company history of discreteness The Fly on the Wall
View ArticleValeant May Improve Allergan Bid on Investor Feedback
Valeant May Improve Allergan Bid on Investor Feedback Bloomberg
View ArticleMergers seem to be a prescription for growth for pharmaceuticals
Mergers seem to be a prescription for growth for pharmaceuticals Yahoo/Market Realist
View ArticleValeant to consider breakup after mega deals -investors
Valeant to consider breakup after mega deals -investors Reuters
View ArticleAckman says Allergan CEO has conflict of interest on takeover offer
Ackman says Allergan CEO has conflict of interest on takeover offer Reuters
View Article